Setting

Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248055 | Pages: 102

Asia Pacific biosurgery market will grow by 8.9% annually with a total addressable market cap of $33.2 billion over 2021-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population. Highlighted with 31 tables and 49 figures, this 102-page report “Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hemostatic Agents • Bone-graft Substitutes o Synthetic Graft Extender o Demineralized Bone Matrix o Bone Morphogenetic Proteins o Cell-Based Matrices • Surgical Sealants and Adhesives o Natural Surgical Sealing Agents o Synthetic Surgical Sealing Agents • Soft-tissue Attachments o Natural & Biological Mesh/Patch o Synthetic Mesh/Patch • Adhesion Barriers o Natural Adhesion Barriers o Synthetic Adhesion Barriers • Staple Line Reinforcement Based on Source Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Gynecological Surgery • Other Applications Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company (C.R. Bard) Betatech Medical CryoLife Inc. CSL Limited Hemostasis LLC Integra Lifesciences Holdings Corporation Johnson & Johnson Medtronic PLC Pfizer, Inc. Sanofi S.A. Stryker Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	6
1.1 Industry Definition and Research Scope	6
1.1.1 Industry Definition	6
1.1.2 Research Scope	7
1.2 Research Methodology	10
1.2.1 Overview of Market Research Methodology	10
1.2.2 Market Assumption	11
1.2.3 Secondary Data	11
1.2.4 Primary Data	11
1.2.5 Data Filtration and Model Design	12
1.2.6 Market Size/Share Estimation	13
1.2.7 Research Limitations	14
1.3 Executive Summary	15
2 Market Overview and Dynamics	17
2.1 Market Size and Forecast	17
2.1.1 Impact of COVID-19 on World Economy	18
2.1.2 Impact of COVID-19 on the Market	20
2.2 Major Growth Drivers	22
2.3 Market Restraints and Challenges	26
2.4 Emerging Opportunities and Market Trends	29
2.5 Porter’s Fiver Forces Analysis	33
3 Segmentation of Asia Pacific Market by Product	37
3.1 Market Overview by Product	37
3.2 Hemostatic Agents	39
3.3 Bone-graft Substitutes	40
3.2.1 Synthetic Graft Extender	41
3.2.2 Demineralized Bone Matrix	42
3.2.3 Bone Morphogenetic Proteins	43
3.2.4 Cell-Based Matrices	44
3.4 Surgical Sealants and Adhesives	45
3.4.1 Natural Surgical Sealing Agents	46
3.4.2 Synthetic Surgical Sealing Agents	47
3.5 Soft-tissue Attachments	48
3.5.1 Natural & Biological Mesh/Patch	49
3.5.2 Synthetic Mesh/Patch	50
3.6 Adhesion Barriers	51
3.6.1 Natural Adhesion Barriers	52
3.6.2 Synthetic Adhesion Barriers	53
3.7 Staple Line Reinforcement	54
4 Segmentation of Asia Pacific Market by Source Type	55
4.1 Market Overview by Source Type	55
4.2 Natural/Biological Products	57
4.3 Synthetic Products	58
5 Segmentation of Asia Pacific Market by Application	60
5.1 Market Overview by Application	60
5.2 Orthopedic Surgery	62
5.3 General Surgery	63
5.4 Neurological Surgery	64
5.5 Cardiovascular Surgery	65
5.6 Gynecological Surgery	66
5.7 Other Applications	67
6 Asia-Pacific Market 2020-2027 by Country	68
6.1 Overview of Asia-Pacific Market	68
6.2 China	71
6.3 Japan	73
6.4 India	76
6.5 Australia	78
6.6 South Korea	80
6.7 Rest of APAC Region	82
7 Competitive Landscape	84
7.1 Overview of Key Vendors	84
7.2 New Product Launch, Partnership, Investment, and M&A	87
7.3 Company Profiles	88
B. Braun Melsungen AG	88
Baxter International, Inc.	90
Becton, Dickinson and Company (C.R. Bard)	91
Betatech Medical	92
CryoLife Inc.	93
CSL Limited	94
Hemostasis LLC	95
Integra Lifesciences Holdings Corporation	96
Johnson & Johnson	97
Medtronic PLC	98
Pfizer, Inc.	99
Sanofi S.A.	100
Stryker Corporation	101
RELATED REPORTS	102
List Of Tables

Table 1.  Snapshot of Asia Pacific Biosurgery Market in Balanced Perspective, 2020-2027	16
Table 2. Growth Rate of World GDP, 2020-2022	19
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Biosurgery Market	29
Table 4. Asia Pacific Biosurgery Market by Product, 2017-2027, $ mn	37
Table 5. Asia Pacific Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn	40
Table 6. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn	45
Table 7. Asia Pacific Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn	48
Table 8. Asia Pacific Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn	51
Table 9. Asia Pacific Biosurgery Market by Source Type, 2017-2027, $ mn	55
Table 10. Asia Pacific Biosurgery Market by Application, 2017-2027, $ mn	60
Table 11. APAC Biosurgery Market by Country, 2017-2027, $ mn	69
Table 12. China Biosurgery Market by Product, 2017-2027, $ mn	72
Table 13. China Biosurgery Market by Source Type, 2017-2027, $ mn	72
Table 14. China Biosurgery Market by Application, 2017-2027, $ mn	72
Table 15. Japan Biosurgery Market by Product, 2017-2027, $ mn	75
Table 16. Japan Biosurgery Market by Source Type, 2017-2027, $ mn	75
Table 17. Japan Biosurgery Market by Application, 2017-2027, $ mn	75
Table 18. India Biosurgery Market by Product, 2017-2027, $ mn	77
Table 19. India Biosurgery Market by Source Type, 2017-2027, $ mn	77
Table 20. India Biosurgery Market by Application, 2017-2027, $ mn	77
Table 21. Australia Biosurgery Market by Product, 2017-2027, $ mn	79
Table 22. Australia Biosurgery Market by Source Type, 2017-2027, $ mn	79
Table 23. Australia Biosurgery Market by Application, 2017-2027, $ mn	79
Table 24. South Korea Biosurgery Market by Product, 2017-2027, $ mn	81
Table 25. South Korea Biosurgery Market by Source Type, 2017-2027, $ mn	81
Table 26. South Korea Biosurgery Market by Application, 2017-2027, $ mn	81
Table 27. Biosurgery Market in Rest of APAC by Country/Region, 2017-2027, $ mn	83
Table 28. B. Braun Melsungen AG: Company Snapshot	88
Table 29. B. Braun Melsungen AG: Business Segmentation	88
Table 30. B. Braun Melsungen AG: Product Portfolio	89
Table 31. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn	89
List Of Figures

Figure 1. Research Method Flow Chart	10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	13
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027	15
Figure 4. Asia Pacific Biosurgery Market, 2017-2027, $ mn	17
Figure 5. Impact of COVID-19 on Business	20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biosurgery Market	22
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Biosurgery Market	26
Figure 9. Investment Opportunity Analysis	30
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Biosurgery Market	33
Figure 11. Breakdown of Asia Pacific Biosurgery Market by Product, 2020-2027, % of Revenue	37
Figure 12. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%)	38
Figure 13. Asia Pacific Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn	39
Figure 14. Asia Pacific Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn	40
Figure 15. Asia Pacific Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn	41
Figure 16. Asia Pacific Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn	42
Figure 17. Asia Pacific Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn	43
Figure 18. Asia Pacific Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn	44
Figure 19. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn	45
Figure 20. Asia Pacific Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn	46
Figure 21. Asia Pacific Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn	47
Figure 22. Asia Pacific Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn	48
Figure 23. Asia Pacific Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn	49
Figure 24. Asia Pacific Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn	50
Figure 25. Asia Pacific Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn	51
Figure 26. Asia Pacific Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn	52
Figure 27. Asia Pacific Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn	53
Figure 28. Asia Pacific Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn	54
Figure 29. Breakdown of Asia Pacific Biosurgery Market by Source Type, 2020-2027, % of Revenue	55
Figure 30. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%)	56
Figure 31. Asia Pacific Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn	57
Figure 32. Asia Pacific Biosurgery Market: Synthetic Products, 2017-2027, $ mn	58
Figure 33. Breakdown of Asia Pacific Biosurgery Market by Application, 2020-2027, % of Revenue	61
Figure 34. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)	61
Figure 35. Asia Pacific Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn	62
Figure 36. Asia Pacific Biosurgery Market: General Surgery, 2017-2027, $ mn	63
Figure 37. Asia Pacific Biosurgery Market: Neurological Surgery, 2017-2027, $ mn	64
Figure 38. Asia Pacific Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn	65
Figure 39. Asia Pacific Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn	66
Figure 40. Asia Pacific Biosurgery Market: Other Applications, 2017-2027, $ mn	67
Figure 41. Breakdown of APAC Biosurgery Market by Country, 2020 and 2027, % of Revenue	69
Figure 42. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	70
Figure 43.  Biosurgery Market in China, 2017-2027, $ mn	71
Figure 44.  Biosurgery Market in Japan, 2017-2027, $ mn	74
Figure 45.  Biosurgery Market in India, 2017-2027, $ mn	76
Figure 46.  Biosurgery Market in Australia, 2017-2027, $ mn	78
Figure 47.  Biosurgery Market in South Korea, 2017-2027, $ mn	80
Figure 48.  Biosurgery Market in Rest of APAC, 2017-2027, $ mn	82
Figure 49. Growth Stage of Asia Pacific Biosurgery Industry over the Forecast Period	84
Key Players (this may not be a complete list and extra companies can be added upon request): 
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)